Why Bubs, Collins Foods, Dusk, and Mayne Pharma shares are falling today

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.

a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At the time of writing, the benchmark index is up 0.2% to 7,269.2 points.

Four ASX shares that have failed to follow the market higher today are listed below. Here’s why they are falling:

Bubs Australia Ltd (ASX: BUB)

The Bubs share price has continued its slide and is down a further 1.5% to 29 cents. This morning, analysts at Bell Potter retained their speculative hold rating and slashed their price target on the struggling infant formula company’s shares by 22% to 35 cents. This follows a trading update which revealed that half year revenue is expected be flat despite delivering strong first quarter growth and the much-hyped US expansion.

Collins Foods Ltd (ASX: CKF)

The Collins Foods share price is down a further 4% to $7.73. Investors have been selling this quick service restaurant operator’s shares since the release of its half year results. Collins Foods revealed solid top line growth but significant margin weakness. Unfortunately, the latter is expected to remain in the second half. Though, it is worth noting that Morgans sees value in Collins Foods’ shares after these declines. This morning it retained its add rating with a $9.50 price target.

Dusk Group Ltd (ASX: DSK)

The Dusk share price is down 9% to $1.87. This follows the release of a trading update from the speciality retailer. Dusk revealed that total sales for the first 19 weeks of FY 2023 were up 23.9% on the prior corresponding period. This is a slowdown from 33.2% growth reported for the first 8 weeks of the financial year.

Mayne Pharma Group Ltd (ASX: MYX)

The Mayne Pharma share price is down 19% to 22 cents. This has been driven by the release of a disappointing trading update at the pharmaceutical company’s annual general meeting. For the four months ended 31 October, Mayne Pharma’s revenue from continuing operations came to $59 million. This is down 29.5% over the prior corresponding period.

The post Why Bubs, Collins Foods, Dusk, and Mayne Pharma shares are falling today appeared first on The Motley Fool Australia.

Turn the market pullback to your advantage today

The recent market pullback in stocks has been eye watering…

But there is a silver lining because historically, some millionaires are made in bear markets.

And when investors can find world-class stocks at severe discounts you have to wonder…

Have you got these four ‘pullback stocks’ in your portfolio?

See The 4 Stocks
*Returns as of November 1 2022

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

Motley Fool contributor James Mickleboro has positions in Collins Foods Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Collins Foods Limited. The Motley Fool Australia has recommended BUBS AUST FPO, Collins Foods Limited, and Dusk Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/MTA05g3

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *